Combo of DBT and synthesized mammography has higher detection rate of breast cancer, says study Medha Baranwal6 May 2022 3:30 AM GMTGermany: Digital breast tomosynthesis (DBT) plus synthesized 2D (s2D) mammography can detect more invasive breast cancer than digital mammography...
Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women Hina Zahid10 Feb 2022 3:30 AM GMTA new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with oestrogen receptor positive...
Addition of Hormone Therapy Treatments in Prostate Cancer Patients improves survival: Study Hina Zahid25 Jan 2022 3:30 AM GMTCLEVELAND - Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common forms of treatment. In a...
Targeted drug combination shows unprecedented activity in hard-to-treat high-grade gliomas Hina Zahid27 Nov 2021 3:30 AM GMTInvestigators from Dana-Farber Cancer Institute have found in a clinical trial that a combination of two targeted cancer drugs showed unprecedented,...
Olaparib benefits relapsed ovarian cancer patients, with BRCA1/2 mutation: Lancet Dr Satabdi Saha25 May 2021 4:00 AM GMTRecent research , put forth in The Lancet Oncology, has highlighted Olaparib to be effective in patients with relapsed ovarian cancer and BRCA1/2...
Early Breast screening in women, in their forties saves lives Hina Zahid13 Aug 2020 9:30 AM GMTBreast screening women aged 40-49 reduces breast cancer mortality, with minimal increased overdiagnosis, according to a study led by Queen Mary...
Clinical trial shows promising new treatment for rare Lymphoma Hina Zahid1 Jun 2020 12:30 PM GMTLymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes. A rare subtype, called...
